文献速递生殖医学

经典型半乳糖血症的高促性腺激素性性腺功能减退症难题

The hypergonadotropic hypogonadism conundrum of classic galactosemia.
PubMed 文献 · Hum Reprod Update · 2023-01-01

经典型半乳糖血症(CG)必然累及女性患者,高促性腺激素性性腺功能减退是其沉重并发症。该综述梳理了CG中卵巢损伤的临床表现、分子机制及生育力保存选项,指出早发性卵巢功能不全(POI)诊断带来显著心理负担,抑郁和焦虑发生率高,需早期充分咨询并适时讨论生育力保存。

要点

  • CG女性患者必然发生高促性腺激素性性腺功能减退,但自发妊娠仍可能发生。
  • POI诊断带来显著心理负担,抑郁和焦虑发生率高,需早期充分咨询。
  • 卵巢组织冷冻保存可作为生育力保存选项,但安全性和有效性数据仍有限。

核心结论

  • CG中POI的分子通路阐明可推进对发病机制的认识并开辟新治疗途径。
  • POI诊断带来显著心理负担,抑郁和焦虑发生率高,需早期充分咨询、适当治疗并适时讨论生育力保存选项。
  • 针对遗传缺陷的治疗(如mRNA或基因治疗等核酸治疗)或影响事件级联的治疗正在(前)临床层面探索。

研究设计与样本

  • 综述;除作者本人相关工作外,检索PubMed数据库截至2022年8月的同行评议文章和综述。
  • 检索词包括「经典型半乳糖血症」「性腺损伤」「早发性卵巢功能不全」「生育力」「动物模型」「生育力保存」并结合相关关键词。

主要发现

  • CG中POI的病因未知,但证据显示卵泡发生关键通路存在失调,包括磷脂酰肌醇3-激酶/蛋白激酶B、肌醇通路、丝裂原活化蛋白激酶、胰岛素样生长因子-1和转化生长因子-β信号。
  • GalT基因捕获(GalTKO)小鼠模型近期发现,1月龄卵巢的早期分子改变引发原始卵泡加速生长激活和耗竭,类似患者中所见的进行性卵巢衰竭。
  • 许多女性因不孕接受咨询且多数从未尝试受孕,但自发妊娠仍可能发生。
  • 卵巢组织冷冻保存可作为生育力保存选项,但安全性和有效性结局数据仍有限。

临床怎么用

  • POI诊断带来显著心理负担且抑郁和焦虑发生率高,需早期充分咨询、适当治疗并适时讨论生育力保存选项。
  • 卵巢组织冷冻保存可作为生育力保存选项,但安全性和有效性结局数据仍有限。

局限性

  • 卵巢组织冷冻保存的安全性和有效性结局数据仍有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypergonadotropic hypogonadism is a burdensome complication of classic galactosemia (CG), an inborn error of galactose metabolism that invariably affects female patients. Since its recognition in 1979, data have become available regarding the clinical spectrum, and the impact on fertility. Many women have been counseled for infertility and the majority never try to conceive, yet spontaneous pregnancies can occur. Onset and mechanism of damage have not been elucidated, yet new insights at the molecular level are becoming available that might greatly benefit our understanding. Fertility preservation options have expanded, and treatments to mitigate this complication either by directly rescuing the metabolic defect or by influencing the cascade of events are being explored. OBJECTIVE AND RATIONALE: The aims are to review: the clinical picture and the need to revisit the counseling paradigm; insights into the onset and mechanism of damage at the molecular level; and current treatments to mitigate ovarian damage. SEARCH METHODS: In addition to the work on this topic by the authors, the PubMed database has been used to search for peer-reviewed articles and reviews using the following terms: 'classic galactosemia', 'gonadal damage', 'primary ovarian insufficiency', 'fertility', 'animal models' and 'fertility preservation' in combination with other keywords related to the subject area. All relevant publications until August 2022 have been critically evaluated and reviewed. OUTCOMES: A diagnosis of premature ovarian insufficiency (POI) results in a significant psychological burden with a high incidence of depression and anxiety that urges adequate counseling at an early stage, appropriate treatment and timely discussion of fertility preservation options. The cause of POI in CG is unknown, but evidence exists of dysregulation in pathways crucial for folliculogenesis such as phosphatidylinositol 3-kinase/protein kinase B, inositol pathway, mitogen-activated protein kinase, insulin-like growth factor-1 and transforming growth factor-beta signaling. Recent findings from the GalT gene-trapped (GalTKO) mouse model suggest that early molecular changes in 1-month-old ovaries elicit an accelerated growth activation and burnout of primordial follicles, resembling the progressive ovarian failure seen in patients. Although data on safety and efficacy outcomes are still limited, ovarian tissue cryopreservation can be a fertility preservation option. Treatments to overcome the genetic defect, for example nucleic acid therapy such as mRNA or gene therapy, or that influence the cascade of events are being explored at the (pre-)clinical level. WIDER IMPLICATIONS: Elucidation of the molecular pathways underlying POI of any origin can greatly advance our insight into the pathogenesis and open new treatment avenues. Alterations in these molecular pathways might serve as markers of disease progression and efficiency of new treatment options.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Derks B, Rivera-Cruz G, Hagen-Lillevik S, et al. The hypergonadotropic hypogonadism conundrum of classic galactosemia. Hum Reprod Update. 2023. PMID: 36512573. doi:10.1093/humupd/dmac041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。